CSIMarket Company Name, Ticker, Industry, else..
 
Timber Pharmaceuticals Inc   (TMBR)
Other Ticker:  
 
 
Price: $0.3426 $0.00 0.735%
Day's High: $0.35 Week Perf: -17.8 %
Day's Low: $ 0.32 30 Day Perf: -87.5 %
Volume (M): 322 52 Wk High: $ 3.07
Volume (M$): $ 110 52 Wk Avg: $2.17
Open: $0.34 52 Wk Low: $0.32



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 3
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -15
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 0

Timber Pharmaceuticals Inc
Timber Pharmaceuticals Inc. is a pharmaceutical company that focuses on the development of innovative dermatology treatments. The company aims to address unmet medical needs in various skin conditions, including rare and orphan diseases. They aim to provide safe and effective therapies by utilizing advanced technologies and research methods. Timber Pharmaceuticals Inc. is committed to improving the lives of patients through their dedication to dermatological research and development.


   Company Address: 3 Mountainview Road, Suite 100 Warren 7059 NJ
   Company Phone Number: 636-7163   Stock Exchange / Ticker: NYSE TMBR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Timber Pharmaceuticals Inc

Timber Pharmaceuticals Inc. Reports Revenue Growth in Q2 2023 Financials, Generating Investor Excitement for Future Potential



Location: [Insert Location]
Timber Pharmaceuticals Inc, a major player in the pharmaceutical preparations industry, has recently disclosed its financial performance for the second quarter of 2023. With a revenue of $0.013836 million during this period, the company showcased encouraging growth potential. Furthermore, Timber Pharmaceuticals Inc reported a net loss of $-4.063 million in Q2 2023, a significant improvement compared to a deficit of $-9.496 million in the corresponding period last year.
These promising figures have captured the attention of investors eagerly awaiting Timber Pharmaceuticals Inc's future financial reports. The company is expected to unveil its next financial numbers on November 13, 2023, shedding further light on its performance and growth trajectory.
Timber Pharmaceuticals Inc

Timber Pharmaceuticals Inc Faces Significant Losses, No Revenue Generation in January-March 2023 Period

Timber Pharmaceuticals Inc, a pharmaceutical company operating in the United States, recently released its financial results for the period spanning January to March 31, 2023. The results showed a significant increase in the company's deficit per share, with a deficit of $-1.32 per share compared to $-0.05 per share in the same period the previous year. Additionally, Timber Pharmaceuticals Inc saw a net deficit of $-4.061 million, which is larger than $-3.073 million from a year earlier.
The revenue for this period remained unchanged at $0.00 million, which is the same as the previous year and sequentially from the previous financial reporting period. This means that the company did not generate revenue during this quarter. In comparison, the company had generated revenue of $0.08 million during the same period in the previous year.






Timber Pharmaceuticals Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com